| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $38.6M | +157.7% |
| SG&A Expense | $14.6M | +81.9% |
| Operating Income | -$53.2M | -131.2% |
| Pre-tax Income | -$51.5M | -124.2% |
| Income Tax | $25K | +733.3% |
| Net Income | -$51.5M | -124.3% |
| EPS (Basic) | -$2.10 | -12.3% |
| EPS (Diluted) | -$2.10 | -12.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.4M | -58.7% |
| Short-term Investments | $106.8M | -5.6% |
| Current Assets | $131.5M | -24.6% |
| Total Assets | $135.3M | -22.8% |
| Current Liabilities | $7.8M | +205.2% |
| Total Liabilities | $8.6M | +190.6% |
| Stockholders' Equity | $126.7M | -26.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.1M | -42.8% |
| Capital Expenditures | $195K | +7.7% |
| Investing Cash Flow | $6.9M | +106.1% |
| Financing Cash Flow | $396K | -99.8% |
| Free Cash Flow | -$39.3M | -42.6% |